Epidermal growth factor (EGF) signalling plays a number of important roles in the development of both vertebrates and invertebrates; in fulfilling these roles, the EGF receptor controls a diverse range of cellular functions, such as cell division, cell-fate decisions and differentiation [1, 2] . Upon activation by an extracellular signal, the EGF receptor undergoes dimerisation and autophosphorylation, leading, via the evolutionarily conserved Ras pathway, to modulation of the activity of specific transcription factors in the nucleus. The complexity of cellular functions governed by the EGF receptor implies that its activity must be precisely regulated in the developing organism. Recent studies on EGF receptor signalling have identified a number of molecular components that help ensure the pathway is regulated with the requisite precision; work on this pathway is likely to provide important general insights into cell-cell signalling systems.
In vertebrates, four different EGF receptor homologues constitute the ErbB superfamily. They are activated by small signalling molecules, such as transforming growth factor α (TGF-α), EGF or the Neuregulins, which are all characterised by having one EGF-like motif in their extracellular domain. The Neuregulins are a diverse family of more than fifteen proteins, all generated from a single gene. Some of the isoforms are membrane-tethered and possess a long cytoplasmic domain; as in the case of TGF-α, which is similarly generated as a transmembrane precursor, proteolytic processing is required to generate the active ligand. In these cases, the cytoplasmic protein domains control proteolytic processing of the extracellular domain [3, 4] .
In the fruitfly Drosophila, only one EGF receptor has been identified to date, known as DER for Drosophila EGF receptor. Four ligands are known to modulate the function of the DER: Vein, Gurken and Spitz are activating ligands, whereas Argos is a novel inhibitory ligand. Vein resembles the secreted vertebrate Neuregulin isoforms, whereas Gurken and Spitz resemble TGF-α and are expressed as membrane-bound precursor molecules. Mosaic studies have shown that Spitz can diffuse over several cell diameters, suggesting that in vivo it is proteolytically cleaved to generate the active ligand [5, 6] . In support of this notion, expression of secreted Spitz protein was found to result in prominent activation of DER, whereas expression of a membrane-bound Spitz protein did not lead to DER activation [7] . During embryogenesis, DER activation appears to be mostly provoked by the ubiquitously expressed Spitz protein.
Genetic studies revealed mutations in two other Drosophila genes that lead to a spitz-like mutant phenotype [8] . The rhomboid gene encodes a seven-transmembrane domain protein; and Star encodes a protein with a single transmembrane domain [9, 10] . Both rhomboid and Star act noncell autonomously to promote DER activation [11] . Indeed, localised expression of secreted Spitz in the central nervous system (CNS) midline of a rhomboid mutant embryo was found to rescue the mutant phenotype [12] . These observations suggested that Star and Rhomboid act by controlling the processing of the membrane-bound Spitz into an active, soluble DER ligand. But an elegant series of experiments by Bang and Kintner [13] has now provided evidence for a novel regulatory mechanism of ligand presentation. Their results indicate that it is not the cleavage of the membrane-bound Spitz protein that frees its signalling capacities, but rather the presentation of Spitz by the transmembrane proteins Rhomboid and Star that creates an active signalling molecule. Most interestingly, the interaction of these three proteins depends on their transmembrane or cytoplasmic domains [13] .
The experimental data supporting this model were obtained using a modified Xenopus animal cap assay that Bang and Kintner developed to study the regulation of DER signalling in a highly sensitive manner ( Figure 1 ). In Xenopus animal cap cells, receptor tyrosine kinase activation induces the expression of the brachyury (Xbra) gene via the conserved Ras signalling pathway. Monitoring Xbra expression thus allows a faithful measure of receptor tyrosine kinase activation. Animal cap cells derived from embryos injected solely with Drosophila EGF receptor RNA were unable to activate endogenous Ras signalling. Only when DER, Star, rhomboid and spitz RNAs were coinjected was a robust activation of Xbra observed [13] . As in the Drosophila system, the requirement for Rhomboid and Star for DER activation could be overcome by co-expression of secreted Spitz protein. Furthermore, adding the DER inhibitor Argos efficiently inhibited activation of the DER.
In a number of subsequent experiments, Bang and Kintner [13] found that Rhomboid and Star alone could only weakly stimulate DER activation, but that they show a strong synergistic interaction. This suggests that expressing either Star or Rhomboid alone, or both together, might modulate the level of DER activation. In vivo, however, Star and Rhomboid appear to act as co-dependent factors. Some aspects of DER activity, most notably its function in the developing Drosophila eye, are not affected by rhomboid function. Where do Star and Rhomboid act? Genetic mosaic analyses in Drosophila have shown that Star and Rhomboid act non-cell autonomously [11] . Bang and Kintner [13] confirmed this genetic inference by simple sandwich experiments. They confronted different animal cap cells derived from Xenopus eggs injected with RNAs for DER or Spitz alone, or a combination of Spitz, Rhomboid and Star. These experiments showed that Star and Rhomboid have to be expressed together with Spitz in the signalling cell to elicit Xbra expression in the animal cap cells expressing DER (Figure 1) . Unexpectedly, this approach revealed that expression of Rhomboid and Star in both sending and receiving cells attenuates DER activation, indicating another possible way that DER activity can be fine-tuned in vivo.
How do Star and Rhomboid regulate the activity of Spitz?
In contrast to the situation in Drosophila, activation of the human EGF receptor by TGF-α does not require the presence of Star or Rhomboid. In a simple experiment, Bang and Kintner [13] swapped the intracellular and the transmembrane domains of Spitz and human TGF-α. Surprisingly, they found that activity of the resulting chimeric human TGF-α protein, which was properly transported to the membrane, now required Rhomboid and Star in order to activate the human EGF receptor. Thus, sequences located in the transmembrane or cytoplasmic domain of Spitz keep the extracellular signalling domain in an inactive state (Figure 2 ).
The generation of the active form of TGF-α or of a Neuregulin requires proteolytic cleavage of the ligand from the membrane-bound precursor proteins. For DER activation, cleavage of membrane-bound Spitz, facilitated by Star and Rhomboid, is thought to generate the active signalling molecule. Indeed, in media conditioned by animal cap cells expressing Spitz, Star and Rhomboid, Bang and Kintner [13] were able to demonstrate the presence of soluble Spitz. To disrupt proteolytic cleavage, potential cleavage sites in a stretch of 15 amino acids in the extracellular domain of Spitz were removed (Figure 2) . The resulting Spitz variant still activated DER in a Starand Rhomboid-dependent manner, but no soluble Spitz protein was released, indicating that proteolytic processing of membrane-bound Spitz is not necessary for DER activation. The function of Rhomboid and Star is thus to present Spitz to DER; this may facilitate the proteolytic cleavage of Spitz, though this appears not to be required for the activation of DER signalling.
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Figure 1
The Xenopus animal cap assay system used by Bang and Kintner [13] to analyse the roles of Rhomboid and Star in DER activation. Where does cleavage of the Spitz precursor occur? The results obtained with the Spitz-TGF-α chimeras, and similarities to the proteolytic processing of Notch or β-amyloid precursor protein by the multiple-transmembrane domain protein presenilin-1 [14] , led Bang and Kintner [13] to test whether Spitz too might be cleaved within its transmembrane domain. In order to do so, they generated a chimera combining the extracellular and transmembrane domain of Spitz with the Notch intracellular domain (NICD) lacking the previously identified proteolytic cleavage site close to, or within, the Notch transmembrane domain [15] . The expectation was that, following cleavage in the transmembrane domain, the NICD would be released, translocate to the nucleus and activate target genes [15] [16] [17] . First of all, the chimeric Spitz-NICD protein activated DER in a Rhomboid-and Star-dependent manner (Figure 2) . Thus, the presentation of the Spitz signal to DER works despite an exchange of the cytoplasmic domain. Furthermore, a Notch target gene was activated only when Rhomboid and Star were present, suggesting that the chimeric protein has to be cleaved in the Spitz transmembrane domain, allowing release and subsequent translocation of the NICD into the nucleus. Deletion of the 15 residuelong stretch just outside the transmembrane domain did not interfere with the Rhomboid-and Star-dependent activation of DER, but expression of the Notch target gene could no longer be induced.
These observations nicely show that Rhomboid and Star can act in a cell-autonomous fashion independently of the DER, and suggest that the cytoplasmic domain of Spitz might generate a signal that acts directly in the cell in which it is produced -as has been reported for TGF-β and the Ephrins [18, 19] . Furthermore, the results show that cleavage of Spitz within its transmembrane domain is not necessary to activate the DER. Finally, the interaction of Spitz, Rhomboid and Star appears to depend on the nature of the transmembrane domains, as NICD and cytoplasmic Spitz domains do not share any sequence similarities.
The kind of role of Star and Rhomboid appear to play in ligand presentation or facilitation of proteolytic processing might reflect a more general property of cell-cell signalling systems. Star has been proposed to facilitate processing of Gurken, another activating ligand of DER [20] . Notch signalling controls cell-fate determination in many tissues, and is triggered by transmembrane ligands such as Delta. Delta can be cleaved by the Kuzbanian metalloprotease, and the extracellular fragment antagonises the function of the membrane-bound Delta protein as an activating Notch ligand [21, 22] . Star has been identified as a suppressor of Delta function [23] ; reduction of Star gene function might lead to a reduced release of the extracellular Delta fragment, and thus to enhanced Delta signalling. It remains to be shown how Star and the different Rhomboids function in the regulation of this signalling pathway. 
